| 11. | Plasmin has been shown to interact with Thrombospondin 1, Alpha 2-antiplasmin and IGFBP3.
|
| 12. | Plasmin initiates fibrinolysis by degrading fibrin.
|
| 13. | Serum proteinases such as plasmin catalyze the release of active TGF-? from the complex.
|
| 14. | The release of the growth factor from heparin is mediated by cell-activated plasmin degradation.
|
| 15. | In vitro, plasmin can activate pro-MMP7 to 50 % of its full activity.
|
| 16. | An enzyme called plasmin contained in the endometrium tends to inhibit the blood from clotting.
|
| 17. | Simultaneously, excess circulating thrombin assists in the conversion of plasminogen to plasmin, resulting in fibrinolysis.
|
| 18. | Plasmin mediates the degradation of the extracellular matrix either by itself or in conjunction with matrix metalloproteinases.
|
| 19. | Plasmin cleaves at the site recognizable to trypsin, is considered as the most possible physiological activator.
|
| 20. | This drug is made by transgenic bacteria and it converts plasminogen into the clot-dissolving enzyme plasmin.
|
